Logiscreen

Organogenesis Holdings Inc - Class A

$2.42
Market Cap 311.31M
ROE -7.2%
Gross Margin 30.8%
Debt/Equity 0.3
Current Ratio 3.5
Revenue QoQ -57.1%
EPS QoQ 1.6%
F-Score 2

About

Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.

Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-17.05
vs median 33.61
P/B
1.30
vs median 2.16
ROE
-0.07
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics